Sexual behavior-related exposures, sexually transmitted infections, and viral markers in relation to prostate cancer risk: a systematic review and meta-analysis
6 affiliations
- 1Department of General Practice, People's Hospital of Chongqing Hechuan
- 2Department of Urology, People's Hospital of Chongqing Hechuan
- 3Department of Urology, Chongqing Rongjun Special Care Hospital (Chongqing Southeast Hospital)
- 4Department of Obstetrics, The Affiliated Banan Hospital of Chongqing Medical University (People’s Hospital of Banan District)
- 5Department of Urology, People’s Hospital of Tongliang District
- 6Department of Hepatobiliary Surgery, Shapingba Hospital Affiliated to Chongqing University (Shapingba District People’s Hospital of Chongqing)
Abstract
Background: Sexual behavior, sexually transmitted infections (STIs), and viral markers have been investigated in relation to prostate cancer, but heterogeneous exposure definitions and ascertainment methods complicate interpretation. We synthesized observational evidence separately across biologically and methodologically distinct exposure domains.
Methods: We followed PRISMA 2020 and searched PubMed/MEDLINE, Embase.com , and Web of Science Core Collection from inception through 27 May 2026. Eligible studies were comparative observational studies evaluating sexual behavior-related exposures, STI history or serology, or viral markers in relation to prostate cancer. Random-effects meta-analysis was performed for sufficiently comparable estimates. Risk of bias was assessed using Newcastle-Ottawa Scale domains, supplemented by design-specific epidemiological considerations. GRADE was used as a post-registration evidence-certainty assessment.
Results: Of 121 reports assessed for eligibility, 57 primary observational reports were included after final eligibility reconciliation. Twenty-five reports entered at least one pooled model and three additional reports appeared only in descriptive forest plots. For tissue- or PCR-based HPV detection, the observed pooled association was OR 3.01 (95% CI 1.97-4.61; I²=36.2%; prediction interval 1.15-7.91; 13 studies). HPV16 and HPV18 tissue/PCR subtype estimates were also elevated, whereas HPV serology showed no clear association. Estimates for Trichomonas vaginalis serology and history-based STI exposure were imprecise or heterogeneous, and sexual-behavior exposures were too heterogeneous for pooling. Certainty was very low across all evaluated exposure domains.
Conclusions: Tissue- or PCR-based HPV detection was more frequent among prostate cancer cases in the available comparative studies, but the evidence is very uncertain because of risk of bias, limited temporal clarity, sampling and comparator differences, and other methodological limitations. These findings should not be interpreted as establishing an etiologic or causal effect and do not support prostate-cancer prevention recommendations based on HPV vaccination, STI screening, or sexual-behavior modification.
Systematic review registration: https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=1334823 , identified: CRD420261334823.
Related
- Prevalence of sexually transmitted infections among pregnant migrant and refugee women: Protocol for a systematic review and meta-analysis
- Sexually Transmitted Infections Among Men Who Have Sex With Men Using Daily and Event-Driven HIV Pre-Exposure Prophylaxis: A Retrospective Cohort Study.
- Sexually Transmitted Infections in the Third Age: Rising Risk Among over 65-Year-Old Persons in Southern Sardinia
- Client, health care provider, and policymaker perspectives on point-of-care/near-point-of-care testing for sexually transmitted infections in community pharmacies in Uganda
- Developing nonlinear time-varying weighted combined prediction framework for infectious diseases: validation with respiratory infectious diseases and sexually transmitted infections
BibTeX
@article{liang2026sexual,
title = {{Sexual behavior-related exposures, sexually transmitted infections, and viral markers in relation to prostate cancer risk: a systematic review and meta-analysis}},
author = {Po Liang and Hong Gu and Jia Liu and Yangming Liu and Liang Chen and Ping Che},
journal = {Frontiers in Oncology},
year = {2026},
month = oct,
doi = {10.3389/fonc.2026.1968570},
url = {https://www.frontiersin.org/articles/10.3389/fonc.2026.1968570/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Sexual behavior-related exposures, sexually transmitted infections, and viral markers in relation to prostate cancer risk: a systematic review and meta-analysis
AU - Po Liang
AU - Hong Gu
AU - Jia Liu
AU - Yangming Liu
AU - Liang Chen
AU - Ping Che
PY - 2026
DA - 2026/10/08
JO - Frontiers in Oncology
DO - 10.3389/fonc.2026.1968570
UR - https://www.frontiersin.org/articles/10.3389/fonc.2026.1968570/full
AB - Background: Sexual behavior, sexually transmitted infections (STIs), and viral markers have been investigated in relation to prostate cancer, but heterogeneous exposure definitions and ascertainment methods complicate interpretation. We synthesized observational evidence separately across biologically and methodologically distinct exposure domains. Methods: We followed PRISMA 2020 and searched PubMed/MEDLINE, Embase.com , and Web of Science Core Collection from inception through 27 May 2026. Eligible studies were comparative observational studies evaluating sexual behavior-related exposures, STI history or serology, or viral markers in relation to prostate cancer. Random-effects meta-analysis was performed for sufficiently comparable estimates. Risk of bias was assessed using Newcastle-Ottawa Scale domains, supplemented by design-specific epidemiological considerations. GRADE was used as a post-registration evidence-certainty assessment. Results: Of 121 reports assessed for eligibility, 57 primary observational reports were included after final eligibility reconciliation. Twenty-five reports entered at least one pooled model and three additional reports appeared only in descriptive forest plots. For tissue- or PCR-based HPV detection, the observed pooled association was OR 3.01 (95% CI 1.97-4.61; I²=36.2%; prediction interval 1.15-7.91; 13 studies). HPV16 and HPV18 tissue/PCR subtype estimates were also elevated, whereas HPV serology showed no clear association. Estimates for Trichomonas vaginalis serology and history-based STI exposure were imprecise or heterogeneous, and sexual-behavior exposures were too heterogeneous for pooling. Certainty was very low across all evaluated exposure domains. Conclusions: Tissue- or PCR-based HPV detection was more frequent among prostate cancer cases in the available comparative studies, but the evidence is very uncertain because of risk of bias, limited temporal clarity, sampling and comparator differences, and other methodological limitations. These findings should not be interpreted as establishing an etiologic or causal effect and do not support prostate-cancer prevention recommendations based on HPV vaccination, STI screening, or sexual-behavior modification. Systematic review registration: https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=1334823 , identified: CRD420261334823.
SN - 2234-943X
ER -